Colin Dwyer
Colin Dwyer covers breaking news for NPR. He reports on a wide array of subjects — from politics in Latin America and the Middle East, to the latest developments in sports and scientific research.
Colin began his work with NPR on the Arts Desk, where he reviewed books and produced stories on arts and culture, then went on to write a daily roundup of news in literature and the publishing industry for the Two-Way blog — named Book News, naturally.
Later, as a producer for the Digital News desk, he wrote and edited feature news coverage, curated NPR's home page and managed its social media accounts. During his time on the desk, he co-created NPR's live headline contest "Head to Head," with Camila Domonoske, and won the American Copy Editors Society's annual headline-writing prize in 2015.
These days, as a reporter for the News Desk, he writes for NPR.org, reports for the network's on-air newsmagazines, and regularly hosts NPR's daily Facebook Live segment, "Newstime." He has covered hurricanes, international elections and unfortunate marathon mishaps, among many other stories. He also had some things to say about shoes once on Invisibilia.
Colin graduated from Georgetown University with a master's degree in English literature.
-
The individuals — three of whom were tried in absentia — were convicted of crimes including membership in a criminal network and complicity in the massacre at the publication and at a kosher market. -
The unanimous judgment represents a stinging reversal for climate activists, who had won a lower-court ruling earlier this year against the major international hub on environmental grounds. -
In a survey by the Kaiser Family Foundation, 71% of respondents said they would definitely or probably get inoculated — a significant leap over the 63% who said so in an August/September poll. -
Amid a spike in new cases, leaders in Germany, the Netherlands and the Czech Republic have announced the return of strict measures to dissuade people from attending large holiday gatherings. -
Army Gen. Gustave Perna told reporters that distribution of the vaccine from Pfizer and BioNTech has begun, with shipment to 636 sites scheduled to begin on Monday. -
The president vowed to "fight on" after the nation's highest court tossed a Texas lawsuit challenging the election results. The reaction from his congressional allies, however, was much more subdued. -
Pfizer and BioNTech's vaccine is the first to receive an emergency authorization from the Food and Drug Administration. Officials say it may be ready for widespread inoculations within days. -
The democracy activist and publisher is perhaps the most prominent individual to be charged under China's controversial new law, which takes aim at dissent in nominally semi-autonomous Hong Kong. -
Earlier this year a court ruled that Franco's 1941 purchase of the property, the Pazo de Meirás, was fraudulent. On Thursday, Spanish officials took possession of the palace. -
The vaccine produced by Pfizer and BioNTech is the first to be authorized by Canadian health officials. The decision makes Canada just the third country in the world to grant such an authorization.
